Pharmacy News

Image description

FDA approves eczema drug

Regeneron’s Dupixent is intended for patients whose eczema is not controlled adequately by topical therapies, or those for whom topical therapies are not advisable.

Image description

Consumer Reports highlights retailer generic savings offers

Consumer Reports is shining a light on the generics savings programs that various retailers offer through their pharmacies, including Walgreens, Rite Aid, Walmart, Costco, Kmart and Sam’s Club. The report notes that while many offer deals on 30- and 90-day generics supplies, many also offer memberships that open up more discounts on other drugs. (Consumer Reports)

Image description

FDA approves ovarian cancer drug

Tesaro’s Zejula is an oral, once-daily poly (ADP-ribose) polymerase (PARP) inhibitor, for the maintenance treatment of women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response (CR or PR) to platinum-based chemotherapy.

Image description

FDA fast-tracks Genentech’s Rituxan

Drug is intended for the treatment of pemphigus vulgaris, a painful, disfiguring and potentially fatal autoimmune disease characterized by progressive blistering of skin and/or mucous membranes.